SCHEMBL20352138

SCHEMBL20352138

CN(C)CCSN1CCN(c2ccc(Br)c(NBc3coc(N)n3)c2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20352057 0.74 — —
SCHEMBL24220411 0.69 PAICS (0.55) —
SCHEMBL20352121 0.68 PAICS (0.36) —
SCHEMBL24220536 0.66 PAICS (0.43) —
SCHEMBL20352137 0.66 PAICS (0.43) —
SCHEMBL20352066 0.65 PAICS (0.45) —
SCHEMBL20339079 0.63 PAICS (0.43) —
SCHEMBL24220478 0.62 PAICS (0.49) —
SCHEMBL20352089 0.62 PAICS (0.49) —
SCHEMBL24220529 0.62 PAICS (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018122549-A1 OXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER LIFEARC (GB) 2018-07-05 — — WO disclosed
Send feedback